One DNA Methylation Regulates CHIP Gene Expression of Human Breast Cancer and Predicts Recurrence

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Carboxyl terminus of Hsc70-interacting protein (CHIP) acts as a ubiquitin ligase, degrading oncoproteins.
• CHIP down-regulation correlates with breast cancer progression and metastasis.
• The precise mechanism of CHIP's influence on cancer cells remains unclear.

Purpose of the Study:

• To investigate the role of CHIP gene expression and its promoter methylation in breast cancer.
• To explore the correlation between CHIP methylation, mRNA expression, and clinicopathological features.
• To determine the impact of CHIP methylation on the prognosis of breast cancer patients.

Main Methods:

• Analysis of CHIP mRNA expression profiles in 45 primary breast cancer samples.
• Assessment of CHIP gene promoter DNA methylation status.
• Correlation of molecular data with clinicopathological information and patient outcomes.

Main Results:

• CHIP mRNA expression significantly correlated with tumor progression status.
• Specific CpG methylation in the CHIP promoter region was associated with CHIP mRNA levels.
• In ER-positive cases, methylation of this CpG site did not lead to a significant difference in 5-year recurrence compared to ER-negative cases.

Conclusions:

• CpG methylation of the CHIP gene promoter is a contributing factor to the long-term prognosis of estrogen receptor-positive breast cancer.
• Epigenetic modifications of CHIP may play a role in breast cancer development and progression.